Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 6
2012 5
2013 8
2014 1
2015 1
2016 2
2017 2
2018 1
2019 4
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Postprandial dysmetabolism: Too early or too late?
Pappas C, Kandaraki EA, Tsirona S, Kountouras D, Kassi G, Diamanti-Kandarakis E. Pappas C, et al. Among authors: kandaraki ea. Hormones (Athens). 2016 Jul;15(3):321-344. doi: 10.14310/horm.2002.1697. Hormones (Athens). 2016. PMID: 27838603 Free article. Review.
Implications and Future Perspectives of AGEs in PCOS Pathophysiology.
Merhi Z, Kandaraki EA, Diamanti-Kandarakis E. Merhi Z, et al. Among authors: kandaraki ea. Trends Endocrinol Metab. 2019 Mar;30(3):150-162. doi: 10.1016/j.tem.2019.01.005. Epub 2019 Feb 1. Trends Endocrinol Metab. 2019. PMID: 30712978 Review.
The Role of Androgen Excess on Insulin Sensitivity in Women.
Diamanti-Kandarakis E, Papalou O, Kandaraki EA. Diamanti-Kandarakis E, et al. Among authors: kandaraki ea. Front Horm Res. 2019;53:50-64. doi: 10.1159/000494902. Epub 2019 Sep 9. Front Horm Res. 2019. PMID: 31499502 Review.
Tailoring treatment for PCOS phenotypes.
Papadakis G, Kandaraki EA, Garidou A, Koutsaki M, Papalou O, Diamanti-Kandarakis E, Peppa M. Papadakis G, et al. Among authors: kandaraki ea. Expert Rev Endocrinol Metab. 2021 Jan;16(1):9-18. doi: 10.1080/17446651.2021.1865152. Epub 2020 Dec 31. Expert Rev Endocrinol Metab. 2021. PMID: 33382003
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.
Alexandraki KI, Kandaraki EA, Poulia KA, Piperi C, Papadimitriou E, Papaioannou TG. Alexandraki KI, et al. Among authors: kandaraki ea. touchREV Endocrinol. 2021 Apr;17(1):37-53. doi: 10.17925/EE.2021.17.1.37. Epub 2021 Apr 28. touchREV Endocrinol. 2021. PMID: 35118445 Free PMC article. Review.
Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease.
Papalou O, Kandaraki EA, Papadakis G, Diamanti-Kandarakis E. Papalou O, et al. Among authors: kandaraki ea. Front Endocrinol (Lausanne). 2019 Mar 1;10:112. doi: 10.3389/fendo.2019.00112. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30881345 Free PMC article. Review.
The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration.
Panidis D, Tziomalos K, Papadakis E, Kandaraki EA, Katsikis I. Panidis D, et al. Among authors: kandaraki ea. Hormones (Athens). 2013 Apr-Jun;12(2):192-200. doi: 10.14310/horm.2002.1403. Hormones (Athens). 2013. PMID: 23933688 Free article. Review.
27 results